Efficacy of CDK 4/6 inhibitors in ER positive metastatic breast cancer: Systematic review and meta-analysis of randomized clinical trials.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.e13040
Abstract: e13040Background: The introduction of cyclin-dependent kinase (CDK) 4/6 inhibitors led to a significant paradigm shift in the management of Estrogen Receptor (ER) positive metastatic breast cancer (MBC). The purpose of this analysis was to evaluate… read more here.
Keywords: cdk inhibitors; inhibitors positive; analysis; breast cancer ... See more keywords